Event
ISTH 2025 Congress
United States
Join us at ISTH 2025Booth #321Exhibit Hours | ![]()
|
Introducing Our Next Generation of Hemostasis Testing Innovation
Join us for a look at our new ACL TOP® Family 70 Series Hemostasis Testing Systems*

Also at the booth:
|
|
Speak with your Werfen rep or signup to request an instrument demonstration or meeting.
Presentation Theater
Bridging the Gap: Lab Testing Strategies for Transitioning Patients from DOACs to Unfractionated Heparin
June 23, 1:45-2:30 PM ET
Exhibit Hall, Presentation Theater 2
As part of the ISTH Congress 2025, you’re invited to attend our education Presentation Theater, featuring Dr. Deepa J Arachchillage, who will discuss strategies for transitioning patients from direct oral anticoagulants (DOAC) to unfractionated heparin (UFH).
A Q&A session with Dr. Arachchillage will follow the presentation.
Presentation Theater Objectives
- Assess current heparin monitoring recommendations (UFH and low molecular weight heparin), testing practice and challenges
- Review the evolution of DOACs, including current availability and indications for use, and recommendations for laboratory measurement
- Describe potential strategies for monitoring UFH in a patient recently transitioned from an anti-Xa DOAC
Featured Speaker
![]() | Deepa J. Arachchillage, MD Consultant Haematologist and Honorary Senior Lecturer |
*Not available in all countries.